Merck Eprova AG
Records under this name other than patents Merck Eprova AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,344,140 | 18F-LABELLED Folates Formerly held In force · High confidence | In force | High confidence | |
| US 9,315,506 | 18F-LABELLED Folates Formerly held In force · High confidence | In force | High confidence | |
| US 9,180,128 | Stable pharmaceutical compositions of 5,10-methylene tetrahydrofolate Formerly held In force · High confidence | In force | High confidence | |
| US 9,265,746 | Method for cell-specific targeting Formerly held In force · High confidence | In force | High confidence | |
| US 7,732,599 | Process for Preparing Tetrahydrobiopterin and Analogs of Tetrahydrobiopterin Formerly held Term ended Term ended Oct 6, 2026 · High confidence | Term ended | Term ended Oct 6, 2026 | High confidence |
| US 7,727,987 | Crystalline Forms of ( 6R)-L-ERYTHRO-TETRAHYDROBIOPTERIN Dihydrochloride Formerly held Term ended Term ended Oct 14, 2025 · High confidence | Term ended | Term ended Oct 14, 2025 | High confidence |
| US 8,067,416 | Methods and compositions for the treatment of metabolic disorders Formerly held Term ended Term ended Jul 27, 2025 · From the USPTO record | Term ended | Term ended Jul 27, 2025 | From the USPTO record |
| US 7,566,714 | Methods and compositions for the treatment of metabolic disorders Formerly held Term ended Term ended Nov 17, 2024 · From the USPTO record | Term ended | Term ended Nov 17, 2024 | From the USPTO record |
| US 8,318,745 | Crystalline Forms of (6R)-L-ERYTHRO-TETRAHYDROBIOPTERIN Dihydrochloride Formerly held Term ended Term ended Nov 17, 2024 · High confidence | Term ended | Term ended Nov 17, 2024 | High confidence |
| US 8,344,139 | Process for Preparing Crystalline Polymorphic Forms of (6R)-L-ERYTHRO-TETRAHYDROBIOPTERIN Dihydrochloride Formerly held Term ended Term ended Nov 17, 2024 · High confidence | Term ended | Term ended Nov 17, 2024 | High confidence |